Loading…

Fenofibrate, a peroxisome proliferator-activated receptor α ligand, prevents abnormal liver function induced by a fasting–refeeding process

•A fasting–refeeding high fat diet (HDF) model mimics irregular eating habit.•A fasting–refeeding HFD induces liver ballooning injury.•A fasting–refeeding HDF process elicits hepatic triglyceride accumulation.•Fenofibrate, PPARα ligand, prevents liver damage induced by refeeding HFD. Fenofibrate, a...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical and biophysical research communications 2013-12, Vol.442 (1-2), p.22-27
Main Authors: Lee, Joon No, Dutta, Raghbendra Kumar, Kim, Seul-Gi, Lim, Jae-Young, Kim, Se-Jin, Choe, Seong-Kyu, Yoo, Kyeong-Won, Song, Seung Ryel, Park, Do-Sim, So, Hong-Seob, Park, Raekil
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•A fasting–refeeding high fat diet (HDF) model mimics irregular eating habit.•A fasting–refeeding HFD induces liver ballooning injury.•A fasting–refeeding HDF process elicits hepatic triglyceride accumulation.•Fenofibrate, PPARα ligand, prevents liver damage induced by refeeding HFD. Fenofibrate, a peroxisome proliferator-activated receptor α (PPARα) agonist, is an anti-hyperlipidemic agent that has been widely used in the treatment of dyslipidemia. In this study, we examined the effect of fenofibrate on liver damage caused by refeeding a high-fat diet (HFD) in mice after 24h fasting. Here, we showed that refeeding HFD after fasting causes liver damage in mice determined by liver morphology and liver cell death. A detailed analysis revealed that hepatic lipid droplet formation is enhanced and triglyceride levels in liver are increased by refeeding HFD after starvation for 24h. Also, NF-κB is activated and consequently induces the expression of TNF-α, IL1-β, COX-2, and NOS2. However, treating with fenofibrate attenuates the liver damage and triglyceride accumulation caused by the fasting–refeeding HFD process. Fenofibrate reduces the expression of NF-κB target genes but induces genes for peroxisomal fatty acid oxidation, peroxisome biogenesis and mitochondrial fatty acid oxidation. These results strongly suggest that the treatment of fenofibrate ameliorates the liver damage induced by fasting–refeeding HFD, possibly through the activation of fatty acid oxidation.
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2013.10.140